Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
New emerging targets in cancer immunotherapy: the role of neoantigens.
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control.
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144.
Extremely low viral reservoir in treated chronically HIV-1-infected individuals.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients.
HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic.